Literature DB >> 12206771

Computational de novo design, and characterization of an A(2)B(2) diiron protein.

Christopher M Summa1, Michael M Rosenblatt, Jae-Kyoung Hong, James D Lear, William F DeGrado.   

Abstract

Diiron proteins are found throughout nature and have a diverse range of functions; proteins in this class include methane monooxygenase, ribonucleotide reductase, Delta(9)-acyl carrier protein desaturase, rubrerythrin, hemerythrin, and the ferritins. Although each of these proteins has a very different overall fold, in every case the diiron active site is situated within a four-helix bundle. Additionally, nearly all of these proteins have a conserved Glu-Xxx-Xxx-His motif on two of the four helices with the Glu and His residues ligating the iron atoms. Intriguingly, subtle differences in the active site can result in a wide variety of functions. To probe the structural basis for this diversity, we designed an A(2)B(2) heterotetrameric four-helix bundle with an active site similar to those found in the naturally occurring diiron proteins. A novel computational approach was developed for the design, which considers the energy of not only the desired fold but also alternatively folded structures. Circular dichroism spectroscopy, analytical ultracentrifugation, and thermal unfolding studies indicate that the A and B peptides specifically associate to form an A(2)B(2) heterotetramer. Further, the protein binds Zn(II) and Co(II) in the expected manner and shows ferroxidase activity under single turnover conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12206771     DOI: 10.1016/s0022-2836(02)00589-2

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  55 in total

1.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

2.  Folding simulations of a de novo designed protein with a betaalphabeta fold.

Authors:  Yifei Qi; Yongqi Huang; Huanhuan Liang; Zhirong Liu; Luhua Lai
Journal:  Biophys J       Date:  2010-01-20       Impact factor: 4.033

3.  Designing functional metalloproteins: from structural to catalytic metal sites.

Authors:  Melissa L Zastrow; Vincent L Pecoraro
Journal:  Coord Chem Rev       Date:  2013-09       Impact factor: 22.315

4.  Design of amphiphilic protein maquettes: controlling assembly, membrane insertion, and cofactor interactions.

Authors:  Bohdana M Discher; Dror Noy; Joseph Strzalka; Shixin Ye; Christopher C Moser; James D Lear; J Kent Blasie; P Leslie Dutton
Journal:  Biochemistry       Date:  2005-09-20       Impact factor: 3.162

5.  Orientation and oligomerization specificity of the Bcr coiled-coil oligomerization domain.

Authors:  Christina M Taylor; Amy E Keating
Journal:  Biochemistry       Date:  2005-12-13       Impact factor: 3.162

6.  Heterochromia in designed metallopeptides: geometry-selective binding of CdII in a de novo peptide.

Authors:  Olga Iranzo; Chris Cabello; Vincent L Pecoraro
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

Review 7.  Challenges in the computational design of proteins.

Authors:  María Suárez; Alfonso Jaramillo
Journal:  J R Soc Interface       Date:  2009-03-11       Impact factor: 4.118

8.  Circular permutation directs orthogonal assembly in complex collagen peptide mixtures.

Authors:  Fei Xu; Teresita Silva; Mihir Joshi; Sohail Zahid; Vikas Nanda
Journal:  J Biol Chem       Date:  2013-09-16       Impact factor: 5.157

9.  Artificial Diiron Enzymes with a De Novo Designed Four-Helix Bundle Structure.

Authors:  Marco Chino; Ornella Maglio; Flavia Nastri; Vincenzo Pavone; William F DeGrado; Angela Lombardi
Journal:  Eur J Inorg Chem       Date:  2015-07-06       Impact factor: 2.524

10.  Harnessing natures ability to control metal ion coordination geometry using de novo designed peptides.

Authors:  Anna F A Peacock; Olga Iranzo; Vincent L Pecoraro
Journal:  Dalton Trans       Date:  2009-01-16       Impact factor: 4.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.